IgE and T-cell receptors

This entry incorrectly conflates two distinct classes of immune recognition molecules: Immunoglobulin E (IgE) and the T-cell receptor (TCR). Immunoglobulin E (IgE) is a class of antibody involved in allergic responses and anti-parasitic immunity, binding to FcεRI receptors on mast cells and basophils. The T-cell receptor (TCR) is a heterodimeric transmembrane protein on T lymphocytes crucial for adaptive immunity, recognizing peptide antigens presented by MHC molecules and initiating T cell responses. Each molecule has unique molecular structures, functions, therapeutic relevance, and associated drug targets, and should be treated as separate entities for accurate biological and pharmacological annotation.

Due to the conflation of two distinct molecules, the mechanisms of action for therapeutic intervention are diverse. For IgE, mechanisms include neutralization of IgE activity by antibody binding or inhibition of its interaction with the FcεRI receptor. For the TCR, mechanisms can involve blockade of antigen recognition, modulation of TCR signaling, or the use of engineered TCRs in adoptive cell therapies.